Title: Gut microbiota in patients with kidney stones: a systematic review and meta-analysis
Authors: Tianhui Yuan, Yuqi Xia, Bojun Li, Weimin Yu, Ting Rao, Zehua Ye, Xinzhou Yan, Baofeng Song, Lei Li, Fangyou Lin, Fan Cheng
Section: Declarations
microbiome and its metabolites in metabolic diseases. Protein Cell. 2021;12(5):360–73. https:// doi. org/ 10. 1007/ s13238- 020- 00814-7. 14. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, et al. Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians. Clin Gastroenterol Hepatol. 2019;17(2):218–30. https:// doi. org/ 10. 1016/j. cgh. 2018. 09. 017. 15. Fraher MH, O’Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol. 2012;9(6):312–22. https:// doi. org/ 10. 1038/ nrgas tro. 2012. 44. 16. Morgan XC, Huttenhower C. Meta’omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 2014;146(6):1437-48.e1. https:// doi. org/ 10. 1053/j. gastro. 2014. 01. 049. 17. Stanford J, Charlton K, Stefoska-Needham A, Ibrahim R, Lambert K. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature. BMC Nephrol. 2020;21(1):215. https:// doi. org/ 10. 1186/ s12882- 020- 01805-w. 18. Qian Y, Yang X, Xu S, Huang P, Li B, Du J, et al. Gut metagenomicsderived genes as potential biomarkers of Parkinson’s disease. Brain. 2020;143(8):2474–89. https:// doi. org/ 10. 1093/ brain/ awaa2 01. 19. Yang K, Niu J, Zuo T, Sun Y, Xu Z, Tang W, et al. Alterations in the Gut Virome in Obesity and Type 2 Diabetes Mellitus. Gastroenterology. 2021;161(4):1257-69.e13. https:// doi. org/ 10. 1053/j. gastro. 2021. 06. 056. 20. Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med. 2019;17(1):5. https:// doi. org/ 10. 1186/ s12967- 018- 1756-4. 21. Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. https:// doi. org/ 10. 1186/ s40168- 016- 0222-x. 22. Stavropoulou E, Kantartzi K, Tsigalou C, Aftzoglou K, Voidarou C, Konstantinidis T, et al. Microbiome, Immunosenescence, and Chronic Kidney Disease. Front Med. 2021;8:661203. https:// doi. org/ 10. 3389/ fmed. 2021. 661203. 23. Zhao J, Bai M, Ning X, Qin Y, Wang Y, Yu Z, et al. Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy. J Am Soc Nephrol. 2022;33(12):2276–92. https:// doi. org/ 10. 1681/ asn. 20220 20189. 24. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. https:// doi. org/ 10. 1007/ s10654- 010- 9491-z. 25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses.